Labs

Our lab studies how genetic and environmental factors intersect to influence cancer risk.

Our ultimate goal is to see the implementation of meaningful discoveries in basic biology help drive novel clinical outcomes.

We are interested in identifying and characterizing the genetic and epigenetic events that induce cancer and maintain tumors.

DeNardo’s laboratory looks at understanding how immune responses shape and are shaped by malignancies.

We study the life history of tumor genomes to improve cancer treatment.

Our research focuses on fundamental and translational aspects of leukemia and stem cell biology.

Our laboratory focuses on Natural Killer (NK) cell biology and therapeutics, as well as leukemia/lymphoma genomics and immunotherapy.

The focus of the lab is on developing methods of applied bioinformatics for personalized medicine and improved cancer care.

We integrate technologies (proteomic, optogenetic, computational, chemical, molecular) to understand how signaling networks are regulated.

Identifying therapeutic targets and biomarkers in Malignant Peripheral Nerve Sheath Tumors.